Background
Clinical features and diagnostic criteria of DLB
Overlap | Dissimilarities |
---|---|
Rigidity, akinesia Cognitive impairments Frontal executive dysfunction Visual-constructive impairment Mild language impairment Mood disturbances (depression, anxiety) REM sleep behavior disorder (RBD) Neuroleptic sensitivity | Some cognitive dysfunctions: deficiencies of attention greater, episodic verbal memory tasks lower in DLB Tremor less frequent in DLB Motor performance: slower walk and poorer balance in DLB Hallucinations (visual) more frequent in DLB Relative timing of dementia and parkinsonism (one year rule) Onset of dementia earlier in PDD Orthostatic hypotension more frequent in DLB Frontal/temporal-associated cognitive subsets more severe in DLB, cognitive decline is faster in DLB/DLB+AD Delusions, visual hallucinations, and attentional fluctuation more frequent in DLB Visual hallucinations: spontaneous in DLB; after L-dopa therapy in PDD, but also in drug-naive cases |
Clinical features and diagnostic guidelines of PDD
Epidemiology and natural history of DLB and PDD
Diagnostic tests (Table 2)
Neuroimaging
Overlap | Dissimilarities |
---|---|
Decreased DAT binding in putamen Reduced cardiac MIBG binding Medial temporal lobe relative preservation Occipital hypoperfusion Similar EEG abnormalities Similar metabolic decrease in cerebral cortex GBA mutations | Grey matter cortical atrophy more frequent and more severe in DLB White matter hyperintensities in temporal lobe more severe and more frequent in DLB Different functional connectivity, corticostriatal disruption:PDD: frontal cortical disruption; DLB: parietal and occipital disruption Greater amyloid binding in DLB Tau-PET imaging more severe in DLB Several genetic differences (APOE ε4, TFAM)) Decreased DAT binding in caudate related to functional impairment in DLB, not in PDD SN sonography (size, asymmetry) CSF AD profile more common in DLB CSF αSyn oligomeres increased in PDD |
Electrophysiology and other studies
Genetics
Gene | DLB | PDD |
---|---|---|
GBA (glucocerebrosidase) | ||
MAPT (microtubule-associated protein tau) H1 haplotype | Associated with increased risk of DLB [284]. | |
APOE (apolipoprotein E) | ||
SNCA (α-synuclein) | ||
COMT (catechol-O-methyltransferase) | ||
UBQLN1 (ubiquilin-1) and FMR1 (fragile X mental retardation protein 1) | ||
LRRK2 (leucine-rich repeat serine/threonine-protein kinase 2) | Not essential for DLB [313]. | |
C9orf72 repeat expansion | Not related with DLB [313]. | |
RAB39B (Ras-related protein Rab-39B) mutations | Not related with DLB [323]. |
Fluid biomarkers
Neuropathology
Morphological overlap
Morphological overlap | Morphological dissimilarities |
---|---|
Variable mixture of cortical and subcortical LB/αSyn pathology and AD-related pathology Similar Braak LB stages (4-6) and neuritic stages (5 or 6) Relationship between pαSyn and tau aggregation to Aβ deposition in frontal and temporal cortex Initial αSyn aggregation in pre-synapses inducing neurodegeneration via interference with axonal transport Postsynaptic protein downregulation | Higher Aβ load in cortex and striatum in DLB Neuritic plaque scores higher in DLB Higher cortical LB load in temporal and parietal cortex in DLB Increased tau loads in cortex and striatum in DLB More frequent and severe αSyn load in hippocampal subareas C2(3) in DLB Minor deviations in lesion pattern in SNc Pedunculopontine cholinergic cell loss in hallucinating PDD, but not in DLB Higher 5-HT1A receptor binding in cerebral cortex in DLB More frequent cerebral microbleeds in DLB |
Morphological differences
Pathogenic aspects
Therapy
Conclusions
Future perspectives
Type of lesion | DLB | PDD |
---|---|---|
LB / αSyn pathology | Both subtypes are characteristic by a combination of progressed LB pathology (LB Braak stage 5–6) and AD pathology of variable severity and extent | |
Aβ load | More severe and extended in cortex and striatum | Less severe and less extended |
Tau load | Higher tau load, particularly in medial temporal cortex | Comparatively low tau load in cortex and striatum |
αSyn load (hippocampus) | CA 1/2 more severely involved | CA 2/3 more frequently involved |
SN neuronal cell loss | Preferentially involving dorsolateral substantia nigra pars compacta | More severe, preferentially involving medioventral SNc |
Pedunculopontine cholinergic cell loss | Negative | Positive in hallucinating PDD |
5-HT1A receptor binding density in cortex | Higher | Lower |
Cortical LB load | Higher in temporal & parietal cortex, hippocampus | Diffuse or focal |